Xingyun Hou, Xu Wan, & Bin Wu. (2019). Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China. Frontiers Media S.A..
Chicago Style (17th ed.) CitationXingyun Hou, Xu Wan, and Bin Wu. Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China. Frontiers Media S.A., 2019.
MLA (9th ed.) CitationXingyun Hou, et al. Cost-Effectiveness of Canagliflozin Versus Dapagliflozin Added to Metformin in Patients With Type 2 Diabetes in China. Frontiers Media S.A., 2019.
Warning: These citations may not always be 100% accurate.